Literature DB >> 20552818

Melkersson-Rosenthal syndrome: lymphoscintigraphy-documented impairment and restoration of facial lymphatic drainage in the course of disease.

M Nittner-Marszalska1, M Krasnowska, K Solarewicz-Madejek, D Jedrzejuk, A Szuba.   

Abstract

Melkersson-Rosenthal syndrome (MRS) is an idiopathic, rare disorder manifested by facial swelling, congenital plicated tongue and recurrent peripheral facial nerve palsy. Labial involvement alone is referred to as cheilitis granulomatosa. Differential diagnosis of MRS includes allergic angioedema, bacterial, viral or filarial infections as well as autoimmunological inflammation in the course of systemic lupus erythematosus, dermatomyositis, and others. We present 4 patients who experienced periodically painless edema of the face and/or lips. Lesions were diagnosed as recurrent Quincke's edema and were treated with antihistamine agents and glucocorticoids without improvement. In all four cases of MRS, we were able to document impaired lymphatic drainage from the swollen area using lymphoscintigraphy. We also documented in follow-up lymphoscintigraphy a restoration of lymphatic flow in three of the four patients with MRS and these results corresponded with clinical improvement. We have demonstrated that lymphatic pathology plays an important role in pathophysiology of chronic facial swelling in patients with Melkersson-Rosenthal syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 20552818

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  3 in total

1.  Melkersson-Rosenthal syndrome.

Authors:  Soaham Dilip Desai; Priyanka Dumraliya; Deepak Mehta
Journal:  J Neurosci Rural Pract       Date:  2014-11

2.  Edemas of the face and lymphoscintigraphic examination.

Authors:  Pierre Bourgeois; E Peters; A Van Mieghem; A Vrancken; G Giacalone; A Zeltzer
Journal:  Sci Rep       Date:  2021-03-19       Impact factor: 4.379

3.  Angioedema, ACE inhibitor and COVID-19.

Authors:  Ekjot Grewal; Bayu Sutarjono; Ibbad Mohammed
Journal:  BMJ Case Rep       Date:  2020-09-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.